The pruritus receptor unit: A target for novel therapies

Journal of Investigative Dermatology

Volumn 127, Issue 8, 2007, Pages 1857-1859

  Yosipovitch, Gil ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CANNABINOID RECEPTOR AGONIST; CYTOKINE; PIMECROLIMUS; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTANOID RECEPTOR; PROSTANOID THROMBOXANE A; TACROLIMUS; UNCLASSIFIED DRUG;

CELL INFILTRATION; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; KERATINOCYTE; NERVE FIBER C; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKIN INFLAMMATION; SKIN PRURITUS; SKIN SENSATION;

EID: 34447546641     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700818     Document Type: Note

References (16)

1. 2 induces itch-associated responses through TP receptors in the skin in mice. J Invest Dermatol 127:2042-2047
2. Andoh T, Yageta Y, Takeshima H, Kuraishi Y (2004) Intradermal nociceptin elicits itch-associated responses through leukotriene B(4) in mice. J Invest Dermatol 123:196-201
3. Bigliardi-Qi M, Lipp B., Sumanovski LT, Buechner SA, Bigliardi PL (2005) Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology 210:91-9
4. Dunford PJ, Williams KN, Desai PJ, Karlsson L, McQueen D, Thurmond RL (2007) Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 119:176-83
5. Hagermark O, Strandberg K, Hamberg M (1977) Potentiation of itch and flare responses in human skin by prostaglandins E2 and H2 and a prostaglandin endoperoxide analog. J Invest Dermatol 69:527-30
6. Han SK, Mancino V, Simon MI (2006) Phospholipase Cbeta 3 mediates the scratching response activated by the histamine H1 receptor on C-fiber nociceptive neurons. Neuron 52:691-703
7. Lippert U, Artuc M, Grutzkau A, Babina M, Guhl S, Haase I et al. (2004) Human skin mast cells express H2 and H4, but not H3 receptors. J Invest Dermatol 123:116-23
8. Nakamura T, Hirasawa Y, Takai T, Mitsuishi K, Okuda M, Kato T et al. (2006) Reduction of skin barrier function by proteolytic activity of a recombinant house dust mite major allergen Der f 1. J Invest Dermatol 126:2719-23
9. Rukweid R, Dvorak M, Watkinson A, McGlone F (2004) Putative role of cannabinoids in experimentally induced itch and inflammation in human skin. In: Itch: Basic Mechanisms and Therapy (Yosipovitch G, Greaves MW, Fleischer Jr AB, McGlone F, eds), Marcel Dekker: New York, 115-30
10. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L et al. (2006) IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117:411-7
11. Stander S, Reinhardt HW, Luger TA (2006) [Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus]. Hautarzt 57:801-7
12. Steinhoff M, Bienenstock J, Schmelz M, Maurer M, Wei E, Biro T (2006) Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol 126:1705-18
13. Sugimoto M, Arai I, Futaki N, Honma Y, Sakurai T, Hashimoto Y et al. (2007) Putative mechanism of the itch-scratch circle: repeated scratching decreases the cutaneous level of prostaglandin D(2), a mediator that inhibits itching. Prostaglandins Leukot Essent Fatty Acids 76: 93-101
14. Toyoda M, Nakamura M, Makino, T, Hino T, Kagoura M, Morohashi M (2002) Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 147:71-9
15. Yosipovitch G, Sugeng MW, Chan YH, Goon A, Ngim S, Goh CL (2001) The effect of topically applied aspirin on localized circumscribed neurodermatitis. J Am Acad Dermatol 45:910-3
16. Yosipovitch G, Yosipovitch Z, Harell D, Ashkenazi I, Erman A (1995) Diurnal rhythm of prostanoid secretion from bone/marrow organ in the rat. Bone 17:79-83